— Know what they know.
Not Investment Advice

RLAY NASDAQ

Relay Therapeutics, Inc.
1W: +6.9% 1M: -17.3% 3M: +57.0% YTD: +67.0% 1Y: +347.9% 3Y: +36.7% 5Y: -53.2%
$13.53
-0.13 (-0.95%)
 
Weekly Expected Move ±8.8%
$10 $11 $12 $13 $14
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 43 · $2.6B mcap · 143M float · 2.34% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -520.5%  ·  5Y Avg: -194.5%
Cost Advantage
34
Intangibles
55
Switching Cost
35
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RLAY shows a Weak competitive edge (44.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -520.5% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$26
Low
$26
Avg Target
$27
High
Based on 2 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 14Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$23.00
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-20 Barclays $17 $27 +10 +123.7% $12.07
2026-05-19 UBS Initiated $26 +101.8% $12.88
2026-04-29 H.C. Wainwright $19 $25 +6 +91.9% $13.03
2026-04-28 Oppenheimer $14 $18 +4 +20.4% $14.95
2026-04-28 Wells Fargo $13 $21 +8 +40.5% $14.95
2026-04-28 Goldman Sachs Salveen Richter Initiated $22 +47.2% $14.95
2026-03-13 Guggenheim Brad Canino Initiated $22 +103.4% $10.81
2026-01-26 Oppenheimer $25 $14 -11 +88.4% $7.43
2025-12-12 Wells Fargo Initiated $13 +66.7% $7.80
2024-09-16 H.C. Wainwright Robert Burns Initiated $19 +150.0% $7.60
2024-09-10 Jefferies Akash Tewari $12 $16 +4 +68.2% $9.51
2024-09-09 Barclays Peter Lawson $15 $17 +2 +78.8% $9.51
2024-09-04 Bank of America Securities Jason Gerberry Initiated $20 +212.0% $6.41
2024-05-09 Barclays Peter Lawson $23 $15 -8 +124.7% $6.68
2024-05-06 Oppenheimer Matt Biegler $33 $25 -8 +255.1% $7.04
2023-04-19 Jefferies Akash Tewari Initiated $12 +1.2% $12.35
2023-02-03 Oppenheimer Initiated $33 +45.0% $22.76
2022-09-30 Barclays Peter Lawson Initiated $23 -0.6% $23.14

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RLAY receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-14 C C-
2026-04-30 C- C
2026-04-01 C C-
2026-02-26 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

50 Grade D
Profitability
20
Balance Sheet
84
Earnings Quality
67
Growth
83
Value
37
Momentum
76
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RLAY scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
14.82
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-3.82
Unlikely Manipulator
Ohlson O-Score
-1.84
Bankruptcy prob: 13.8%
Moderate
Credit Rating
A+
Score: 75.6/100
Trend: Improving
Earnings Quality
OCF/NI: 0.78x
Accruals: -8.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RLAY scores 14.82, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RLAY scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RLAY's score of -3.82 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RLAY's implied 13.8% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RLAY receives an estimated rating of A+ (score: 75.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-8.92x
PEG
-0.24x
P/S
242.78x
P/B
3.79x
P/FCF
-8.39x
P/OCF
EV/EBITDA
-4.44x
EV/Revenue
118.71x
EV/EBIT
-4.46x
EV/FCF
-5.94x
Earnings Yield
-15.24%
FCF Yield
-11.92%
Shareholder Yield
0.04%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. RLAY currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.959
EBT / EBIT
×
EBIT Margin
-26.644
EBIT / Rev
×
Asset Turnover
0.014
Rev / Assets
×
Equity Multiplier
1.110
Assets / Equity
=
ROE
-40.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RLAY's ROE of -40.6% is driven by Asset Turnover (0.014), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1471 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$13.53
Median 1Y
$8.56
5th Pctile
$2.41
95th Pctile
$30.50
Ann. Volatility
77.0%
Analyst Target
$23.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sanjiv K. Patel,
M.D. President and Chief Executive Officer
$707,846 $— $4,646,454
Donald Bergstrom, M.D.,
Ph.D. President, Research & Development
$554,250 $— $2,089,663
Thomas Catinazzo Financial
ancial Officer
$486,100 $— $1,568,613
Peter Rahmer Corporate
porate Development Officer
$469,050 $— $1,545,170
Brian Adams Legal
r Chief Legal Officer
$291,182 $— $1,177,329

CEO Pay Ratio

13912:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,646,454
Avg Employee Cost (SGA/emp): $334
Employees: 170,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
170,000
+65034.1% YoY
Revenue / Employee
$90
Rev: $15,355,000
Profit / Employee
$-1,626
NI: $-276,479,000
SGA / Employee
$334
Avg labor cost proxy
R&D / Employee
$1,538
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -31.0% -89.6% -43.8% -46.2% -32.2% -35.0% -31.4% -34.9% -37.3% -35.3% -40.2% -38.7% -37.9% -40.6% -44.2% -43.6% -40.7% -38.9% -41.1% -40.6% -40.56%
ROA -29.6% -43.8% -40.2% -42.4% -29.5% -32.1% -27.6% -30.6% -32.7% -30.9% -35.2% -33.9% -33.2% -35.5% -39.4% -38.9% -36.3% -34.7% -37.0% -36.5% -36.54%
ROIC -1.7% -1.9% 7.7% 8.1% 5.7% 6.2% -26.1% -29.5% -32.0% -30.9% -5.3% -5.2% -5.1% -5.4% -6.5% -6.4% -6.0% -5.7% -5.3% -5.2% -5.20%
ROCE -13.0% -15.9% -23.0% -25.5% -27.4% -29.8% -30.0% -33.4% -36.3% -35.6% -46.6% -45.4% -45.9% -48.5% -47.0% -46.1% -41.8% -39.1% -48.8% -47.8% -47.75%
Gross Margin -52.5% -65.3% -89.1% -122.3% -164.8% -193.5% -251.7% -365.5% -740.2% -2.2% 1.0% 1.0% 1.0% 1.0% 91.4% 83.2% 83.20%
Operating Margin -229.4% -91.6% -119.4% -149.7% -213.2% -249.7% -287.9% -447.7% -891.2% -2.9% 92196.0% -9.0% -11.1% -113.5% -8.7% -26.2% -26.20%
Net Margin -229.1% -91.3% -119.0% -148.1% -210.4% -244.7% -266.8% -417.0% -827.8% -2.6% 83495.0% -8.1% -10.0% -104.0% -7.8% -24.4% -24.43%
EBITDA Margin -68.4% -87.1% -114.6% -158.3% -210.0% -237.2% -325.0% -446.8% -898.1% -2.9% 92888.0% -9.1% -10.9% -112.0% -8.3% -26.0% -26.03%
FCF Margin -49.9% -85.3% -25.7% -70.5% -102.3% -129.6% -172.7% -215.2% -283.2% -10.6% -11.9% -8.1% -8.0% -28.2% -25.1% -35.5% -31.4% -29.8% -15.4% -20.0% -19.99%
OCF Margin -48.3% -82.2% -24.6% -68.2% -98.7% -125.1% -166.2% -208.3% -274.9% -10.4% -11.8% -8.0% -8.0% -28.0% -24.9% -35.4% -31.3% -29.7% -15.3% -20.0% -19.98%
ROE 3Y Avg snapshot only -44.91%
ROE 5Y Avg snapshot only -42.28%
ROA 3Y Avg snapshot only -40.38%
ROIC 3Y Avg snapshot only -2.45%
ROIC Economic snapshot only -39.08%
Cash ROA snapshot only -34.34%
Cash ROIC snapshot only -4.74%
CROIC snapshot only -4.74%
NOPAT Margin snapshot only -21.94%
Pretax Margin snapshot only -25.54%
R&D / Revenue snapshot only 24.18%
SGA / Revenue snapshot only 4.59%
SBC / Revenue snapshot only 5.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -14.23 -11.19 -8.67 -8.45 -6.81 -8.54 -6.22 -6.19 -4.44 -3.15 -3.95 -3.30 -2.68 -2.88 -2.04 -1.33 -1.90 -3.02 -5.25 -6.56 -8.923
P/S Ratio 39.83 34.34 1041.72 1298.57 902.23 1463.70 1308.65 1681.95 1622.41 39.84 52.83 30.74 24.60 99.22 68.89 57.74 70.92 107.69 94.53 167.60 242.780
P/B Ratio 4.41 3.83 3.51 3.61 2.03 2.76 1.90 2.10 1.61 1.08 1.79 1.44 1.15 1.32 0.89 0.57 0.76 1.16 2.56 3.16 3.789
P/FCF -79.79 -40.24 -40.52 -18.42 -8.82 -11.29 -7.58 -7.82 -5.73 -3.74 -4.43 -3.78 -3.06 -3.51 -2.75 -1.63 -2.26 -3.62 -6.15 -8.39 -8.386
P/OCF
EV/EBITDA -27.45 -18.75 -9.99 -9.33 -3.33 -5.34 -2.82 -3.10 -1.58 -0.24 -1.75 -1.07 -0.46 -0.76 0.11 0.78 0.41 -0.53 -3.20 -4.44 -4.444
EV/Revenue 32.10 26.66 732.98 923.90 438.58 911.97 627.13 889.72 623.29 3.36 25.56 11.02 4.81 29.60 -4.34 -37.69 -16.78 19.99 60.53 118.71 118.707
EV/EBIT -26.45 -18.17 -9.82 -9.19 -3.28 -5.27 -2.79 -3.06 -1.56 -0.24 -1.72 -1.05 -0.45 -0.75 0.11 0.76 0.41 -0.52 -3.20 -4.46 -4.455
EV/FCF -64.28 -31.24 -28.51 -13.10 -4.29 -7.03 -3.63 -4.13 -2.20 -0.32 -2.14 -1.35 -0.60 -1.05 0.17 1.06 0.54 -0.67 -3.94 -5.94 -5.940
Earnings Yield -7.0% -8.9% -11.5% -11.8% -14.7% -11.7% -16.1% -16.1% -22.5% -31.7% -25.3% -30.3% -37.3% -34.8% -49.0% -75.2% -52.6% -33.1% -19.0% -15.2% -15.24%
FCF Yield -1.3% -2.5% -2.5% -5.4% -11.3% -8.9% -13.2% -12.8% -17.5% -26.7% -22.6% -26.5% -32.7% -28.5% -36.4% -61.5% -44.2% -27.7% -16.2% -11.9% -11.92%
Price/Tangible Book snapshot only 3.156
EV/Gross Profit snapshot only 143.603
Shareholder Yield snapshot only 0.04%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 56.49 56.49 40.14 40.14 40.14 40.14 16.00 16.00 16.00 16.00 25.44 25.44 25.44 25.44 15.95 15.95 15.95 15.95 22.61 22.61 22.608
Quick Ratio 56.49 56.49 40.14 40.14 40.14 40.14 15.81 15.81 15.81 15.81 25.44 25.44 25.44 25.44 15.95 15.95 15.95 15.95 22.61 22.61 22.608
Debt/Equity 0.03 0.03 0.03 0.03 0.03 0.03 0.06 0.06 0.06 0.06 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.057
Net Debt/Equity -0.86 -0.86 -1.04 -1.04 -1.04 -1.04 -0.99 -0.99 -0.99 -0.99 -0.93 -0.93 -0.93 -0.93 -0.94 -0.94 -0.94 -0.94 -0.92 -0.92 -0.921
Debt/Assets 0.03 0.03 0.02 0.02 0.02 0.02 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.05 0.05 0.052
Debt/EBITDA -0.25 -0.20 -0.10 -0.09 -0.09 -0.08 -0.19 -0.17 -0.16 -0.16 -0.14 -0.15 -0.15 -0.14 -0.13 -0.13 -0.14 -0.15 -0.11 -0.11 -0.114
Net Debt/EBITDA 6.62 5.40 4.21 3.79 3.52 3.23 3.07 2.76 2.53 2.59 1.86 1.91 1.89 1.79 1.93 1.96 2.17 2.32 1.80 1.83 1.831
Interest Coverage
Equity Multiplier 1.05 1.05 1.12 1.12 1.12 1.12 1.16 1.16 1.16 1.16 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.10 1.10 1.096
Cash Ratio snapshot only 21.679
Cash to Debt snapshot only 17.084
FCF to Debt snapshot only -6.574
Defensive Interval snapshot only 663.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.11 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 0.04 0.04 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.014
Inventory Turnover 40.13 45.28 49.85 52.26 41.70 28.03 13.46 0.00
Receivables Turnover 1.13 2.27 0.08 0.07 0.05 0.04 3.90 3.35 2.66 72.78 166.97 230.90 230.12 65.40
Payables Turnover 12.07 18.11 23.38 26.26 28.36 31.47 25.78 29.08 32.02 33.57 25.52 17.15 8.24 0.00 0.00 0.00 0.00 0.06 0.12 0.17 0.170
DSO 324 161 4543 5513 6823 8119 94 109 137 5 2 2 2 6 0 0 0 0 0 0 0.0 days
DIO 0 0 0 0 0 0 9 8 7 7 9 13 27 0 0 0 0.0 days
DPO 30 20 16 14 13 12 14 13 11 11 14 21 44 5687 2954 2150 2149.6 days
Cash Conversion Cycle 294 141 4527 5499 6810 8107 89 104 133 1 -3 -7 -16 -5687 -2954 -2150 -2149.6 days
Fixed Asset Turnover snapshot only 0.256
Cash Velocity snapshot only 0.019
Capital Intensity snapshot only 58.193
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -96.3% -97.0% -97.6% -98.0% -54.4% -52.4% -53.3% 14.2% 17.5% 28.7% 36.4% -61.2% -60.8% -78.3% -76.3% -16.5% 53.5% 39.0% 39.04%
Net Income -6.2% -452.7% -7.9% -13.0% -11.2% 20.2% 15.9% -28.9% -12.2% -17.7% -2.0% 6.3% -5.9% 1.2% -1.3% 3.5% 13.8% 18.1% 18.2% 18.20%
EPS -4.6% -397.2% -6.4% 4.4% 7.0% 32.2% 24.9% -15.1% -1.8% -16.2% 5.4% 14.1% 7.7% 27.7% 21.7% 25.2% 29.9% 20.2% 23.0% 23.03%
FCF -2.0% -30.2% -11.9% -3.9% -2.0% -2.1% -45.2% -29.2% -24.9% -27.6% -12.5% -6.2% -2.9% 17.5% 5.2% 7.5% 11.9% 6.1% 21.7% 21.73%
EBITDA -2.4% -450.8% -5.0% -1.7% -1.4% -38.1% -38.2% -39.8% -25.5% -21.9% -6.6% 1.0% -7.1% -1.6% -2.5% 8.1% 18.7% 23.5% 23.6% 23.56%
Op. Income -6.2% -224.3% -7.7% -13.3% -12.3% 17.9% 12.3% -35.9% -20.2% -24.6% -7.2% 2.5% -7.4% 0.1% -1.3% 3.9% 13.9% 18.7% 19.2% 19.22%
OCF Growth snapshot only 21.56%
Asset Growth snapshot only -28.69%
Equity Growth snapshot only -27.09%
Debt Growth snapshot only -33.08%
Shares Change snapshot only 6.27%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -32.4% -25.0% -25.3% -51.0% 48.9% 45.4% 60.6% 70.2% 1.2% 1.1% 1.08%
Revenue 5Y -28.6% -33.7% -33.74%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y -29.7% -29.9% -29.88%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 40.9% 1.8% 1.8% 1.8% 1.8% -4.8% -4.8% -4.8% -4.8% -17.3% -17.3% -17.33%
Assets 5Y 17.3% -4.9% -4.9% -4.93%
Equity 3Y -0.5% -0.5% -0.5% -0.5% -4.7% -4.7% -4.7% -4.7% -15.8% -15.8% -15.81%
Book Value 3Y -10.2% -12.1% -12.0% -13.3% -19.0% -17.9% -18.1% -17.7% -25.1% -26.2% -26.16%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.00 0.77 0.76 0.76 0.00 0.35 0.24 0.24 0.48 0.28 0.16 0.18 0.19 0.53 0.56 0.563
Earnings Stability 0.84 0.57 0.59 0.94 0.79 0.53 0.45 0.76 0.75 0.46 0.37 0.55 0.57 0.29 0.19 0.194
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.00 1.00 0.50 1.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.96 0.92 0.94 0.88 0.95 0.93 0.99 0.97 0.98 1.00 0.99 0.99 0.94 0.93 0.93 0.927
Earnings Smoothness
ROE Trend -0.10 -0.10 -0.06 -0.01 -0.10 -0.05 -0.10 -0.13 -0.05 -0.04 -0.00 0.02 -0.04 -0.05 -0.048
Gross Margin Trend -147.73 -192.12 -268.57 56.34 106.32 149.06 209.32 74.03 92.92 117.79 161.38 6.04 4.85 2.23 2.228
FCF Margin Trend -159.52 -179.84 -231.79 54.61 87.31 134.71 184.74 41.90 67.23 76.16 114.27 -10.34 3.15 1.83 1.835
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.17 0.27 0.20 0.44 0.75 0.73 0.79 0.77 0.75 0.82 0.88 0.86 0.87 0.81 0.74 0.82 0.84 0.83 0.85 0.78 0.782
FCF/OCF 1.03 1.04 1.05 1.03 1.04 1.04 1.04 1.03 1.03 1.02 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.782
CapEx/Revenue 1.6% 3.1% 1.1% 2.3% 3.6% 4.5% 6.6% 6.9% 8.3% 24.5% 16.2% 11.3% 7.1% 21.3% 20.2% 8.1% 7.6% 4.9% 2.7% 0.2% 0.24%
Accruals Ratio -0.24 -0.32 -0.32 -0.24 -0.08 -0.09 -0.06 -0.07 -0.08 -0.05 -0.04 -0.05 -0.04 -0.07 -0.10 -0.07 -0.06 -0.06 -0.05 -0.08 -0.080
Sloan Accruals snapshot only -0.275
Cash Flow Adequacy snapshot only -8206.038
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.04%
Net Buyback Yield -25.5% -14.7% -12.2% -11.9% -21.2% -15.5% -0.2% -0.2% -0.3% -1.4% -2.5% -7.4% -9.2% -29.0% -38.9% -49.7% -36.8% -0.0% -0.0% -7.8% -7.77%
Total Shareholder Return -25.5% -14.7% -12.2% -11.9% -21.2% -15.5% -0.2% -0.2% -0.3% -1.4% -2.5% -7.4% -9.2% -29.0% -38.9% -49.7% -36.8% -0.0% -0.0% -7.8% -7.77%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 2.31 2.09 1.61 1.53 0.99 0.99 0.93 0.93 0.92 0.88 0.90 0.89 0.86 0.87 0.88 0.88 0.91 0.93 0.95 0.96 0.959
EBIT Margin -1.21 -1.47 -74.65 -100.57 -133.81 -173.18 -225.16 -291.09 -399.58 -14.29 -14.85 -10.46 -10.60 -39.47 -38.54 -49.27 -41.06 -38.40 -18.93 -26.64 -26.644
Asset Turnover 0.11 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 0.04 0.04 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.014
Equity Multiplier 1.05 2.05 1.09 1.09 1.09 1.09 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.12 1.12 1.12 1.12 1.11 1.11 1.110
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.57 $-2.82 $-3.54 $-3.54 $-2.46 $-2.62 $-2.40 $-2.66 $-2.83 $-2.67 $-2.79 $-2.52 $-2.43 $-2.46 $-2.02 $-1.97 $-1.82 $-1.73 $-1.61 $-1.52 $-1.52
Book Value/Share $8.30 $8.23 $8.74 $8.29 $8.26 $8.10 $7.86 $7.83 $7.81 $7.77 $6.13 $5.75 $5.66 $5.36 $4.65 $4.60 $4.54 $4.51 $3.30 $3.15 $3.57
Tangible Book/Share $8.30 $8.23 $8.72 $8.27 $8.24 $8.07 $7.84 $7.81 $7.79 $7.76 $6.12 $5.73 $5.64 $5.35 $4.63 $4.58 $4.53 $4.50 $3.30 $3.15 $3.15
Revenue/Share $0.92 $0.92 $0.03 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01 $0.21 $0.21 $0.27 $0.27 $0.07 $0.06 $0.05 $0.05 $0.05 $0.09 $0.06 $0.06
FCF/Share $-0.46 $-0.78 $-0.76 $-1.63 $-1.90 $-1.98 $-1.97 $-2.11 $-2.19 $-2.25 $-2.48 $-2.20 $-2.13 $-2.02 $-1.50 $-1.61 $-1.53 $-1.44 $-1.37 $-1.19 $-1.19
OCF/Share $-0.44 $-0.75 $-0.72 $-1.57 $-1.83 $-1.91 $-1.90 $-2.04 $-2.13 $-2.19 $-2.45 $-2.17 $-2.11 $-2.00 $-1.49 $-1.61 $-1.53 $-1.44 $-1.37 $-1.19 $-1.19
Cash/Share $7.38 $7.32 $9.32 $8.85 $8.82 $8.64 $8.26 $8.23 $8.21 $8.17 $6.12 $5.73 $5.65 $5.35 $4.67 $4.62 $4.56 $4.53 $3.23 $3.08 $3.57
EBITDA/Share $-1.07 $-1.31 $-2.16 $-2.28 $-2.45 $-2.61 $-2.54 $-2.81 $-3.05 $-2.97 $-3.05 $-2.78 $-2.77 $-2.78 $-2.27 $-2.20 $-1.97 $-1.84 $-1.69 $-1.59 $-1.59
Debt/Share $0.27 $0.26 $0.22 $0.21 $0.21 $0.21 $0.48 $0.48 $0.47 $0.47 $0.44 $0.41 $0.40 $0.38 $0.29 $0.29 $0.28 $0.28 $0.19 $0.18 $0.18
Net Debt/Share $-7.11 $-7.05 $-9.10 $-8.64 $-8.61 $-8.43 $-7.78 $-7.76 $-7.73 $-7.70 $-5.68 $-5.32 $-5.24 $-4.97 $-4.38 $-4.33 $-4.28 $-4.25 $-3.04 $-2.90 $-2.90
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 14.818
Altman Z-Prime snapshot only 26.810
Piotroski F-Score 2 4 2 2 3 3 3 3 2 4 3 4 3 2 3 3 3 3 4 4 4
Beneish M-Score -21.87 -4.08 -3.36 -3.21 -2.64 -2.90 -2.24 106.19 -158.35 -3.11 -3.82 -3.815
Ohlson O-Score snapshot only -1.835
ROIC (Greenblatt) snapshot only -47.86%
Net-Net WC snapshot only $2.91
EVA snapshot only $-238702610.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 74.02 73.71 74.12 74.77 75.45 75.48 76.78 76.20 76.41 64.89 76.71 76.44 65.06 73.63 54.09 44.42 49.83 65.08 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only 31.191
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms